MX2016013340A - Metodos para tratar hipersomnia. - Google Patents

Metodos para tratar hipersomnia.

Info

Publication number
MX2016013340A
MX2016013340A MX2016013340A MX2016013340A MX2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A
Authority
MX
Mexico
Prior art keywords
methods
treating hypersomnia
hypersomnia
treating
channel blocker
Prior art date
Application number
MX2016013340A
Other languages
English (en)
Spanish (es)
Inventor
Lien Lyndon
Original Assignee
Balance Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Balance Therapeutics Inc filed Critical Balance Therapeutics Inc
Publication of MX2016013340A publication Critical patent/MX2016013340A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2016013340A 2014-04-15 2015-04-14 Metodos para tratar hipersomnia. MX2016013340A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461979918P 2014-04-15 2014-04-15
PCT/US2015/025696 WO2015160766A1 (en) 2014-04-15 2015-04-14 Methods for treating hypersomnia

Publications (1)

Publication Number Publication Date
MX2016013340A true MX2016013340A (es) 2017-02-09

Family

ID=54324484

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013340A MX2016013340A (es) 2014-04-15 2015-04-14 Metodos para tratar hipersomnia.

Country Status (12)

Country Link
US (3) US10688103B2 (enExample)
EP (1) EP3131904A4 (enExample)
JP (2) JP6672264B2 (enExample)
KR (1) KR20170005415A (enExample)
CN (1) CN106459066B (enExample)
AU (2) AU2015247829B2 (enExample)
CA (1) CA2945705A1 (enExample)
EA (1) EA201692061A1 (enExample)
IL (1) IL248255A0 (enExample)
MX (1) MX2016013340A (enExample)
WO (1) WO2015160766A1 (enExample)
ZA (1) ZA201607068B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10278977B2 (en) 2016-06-06 2019-05-07 Umecrine Cognition Ab Methods for treating hypersomnolence
US11529358B2 (en) 2017-05-10 2022-12-20 Emory University Treatment of conditions associated with myotonic dystrophy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006137746A (ja) 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
CA2686155C (en) 2006-05-22 2016-11-15 The Board Of Trustees Of The Leland Stanford Junior University Pharmacological treatment of cognitive impairment
JP2010515882A (ja) * 2007-01-05 2010-05-13 アリーナ ファーマシューティカルズ, インコーポレイテッド 睡眠関連障害を含むgaba関連神経学的障害を処置するためのgタンパク質共役受容体およびその調節因子
US9616070B2 (en) * 2008-03-12 2017-04-11 Emory University Use of GABAA receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
US8946206B2 (en) * 2010-12-17 2015-02-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for improving cognitive function
JP2014511382A (ja) 2011-02-23 2014-05-15 コエルルウス リミテッド フルマゼニル錯体、それを含む組成物、およびその使用
ES2579319T3 (es) 2011-05-04 2016-08-09 Balance Therapeutics, Inc. Derivados de pentilenotetrazol

Also Published As

Publication number Publication date
US10688103B2 (en) 2020-06-23
AU2019268190A1 (en) 2019-12-12
EA201692061A1 (ru) 2017-03-31
KR20170005415A (ko) 2017-01-13
US20180169107A1 (en) 2018-06-21
ZA201607068B (en) 2023-01-25
WO2015160766A1 (en) 2015-10-22
IL248255A0 (en) 2016-11-30
EP3131904A1 (en) 2017-02-22
CN106459066B (zh) 2020-07-07
EP3131904A4 (en) 2017-11-22
AU2015247829A1 (en) 2016-10-27
CN106459066A (zh) 2017-02-22
JP2017511386A (ja) 2017-04-20
JP2020105200A (ja) 2020-07-09
US20200360398A1 (en) 2020-11-19
AU2015247829B2 (en) 2019-12-05
CA2945705A1 (en) 2015-10-22
JP6672264B2 (ja) 2020-03-25
US20230115839A1 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
PL3110975T3 (pl) Metody analizy somatycznych elementów ruchomych i ich zastosowania
MA40579A (fr) Anticorps anti-cll-1 et immunoconjugués
EP3137606A4 (en) METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
SG11201605692WA (en) Audio processing device and method, and program therefor
ZA201608164B (en) Systems, apparatus, and methods for generating and analyzing resistome profiles
IL281682A (en) Roller kit, pipe components and method
GB2543202B (en) Well ranging apparatus, methods, and systems
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
EP3125221A4 (en) Encryption processing device, and encryption processing method and program
LT3572405T (lt) Benzoimidazol-1,2-ilo amidai, kaip kv7 kanalų aktyvatoriai
ZA201703498B (en) Kcnq2-5 channel activator
EP3106218A4 (en) Carbon-dioxide capturing material, and carbon-dioxide recovery apparatus using same
JO3541B1 (ar) علاجات طبية قائمة على اناموريلين
GB2556477B (en) Irrigation apparatus and feeding system
MX2016009537A (es) Metodo para tratar ropa.
LT3405213T (lt) Bakteriniai šešėliai, skirti panaudoti vėžio gydyme
GB201405715D0 (en) Methods, apparatus and materials
AU2019268190A1 (en) Methods for treating hypersomnia
SG11201702148RA (en) Acrylic acid-based copolymer, method for producing same and water treatment agent
GB201400767D0 (en) Devices, systems and methods for the whitening of teeth
ZA201605538B (en) Channel decoding method and apparatus, and distributed decoder
MX2016009541A (es) Metodo para tratar vajilla.
MX2017000474A (es) Agente terapeutico para un trastorno queratoconjuntival.
LT3881845T (lt) Trazodono ir gabapentino derinys, skirtas skausmo gydymui
HK1228394A1 (en) Methods for treating hypersomnia